Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $223B |
| FY2017, ended Dec 31, 2017 | $239B |
| FY2018, ended Dec 31, 2018 | $207B |
| FY2019, ended Dec 31, 2019 | $226B |
| FY2020, ended Dec 31, 2020 | $163B |
| FY2021, ended Dec 31, 2021 | $229B |
| FY2022, ended Dec 31, 2022 | $342B |
| FY2023, ended Dec 31, 2023 | $277B |
| FY2024, ended Dec 31, 2024 | $255B |
| FY2025, ended Dec 31, 2025 | $304B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $328B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $114B |
| FY2017, ended Dec 31, 2017 | $142B |
| FY2018, ended Dec 31, 2018 | $166B |
| FY2019, ended Dec 31, 2019 | $147B |
| FY2020, ended Dec 31, 2020 | $94.7B |
| FY2021, ended Dec 31, 2021 | $162B |
| FY2022, ended Dec 31, 2022 | $246B |
| FY2023, ended Dec 31, 2023 | $201B |
| FY2024, ended Dec 31, 2024 | $203B |
| FY2025, ended Dec 31, 2025 | $189B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $215B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$497M | −$5.42B |
| FY2017, ended Dec 31, 2017 | $9.20B | $6.93B |
| FY2018, ended Dec 31, 2018 | $14.8B | $16.8B |
| FY2019, ended Dec 31, 2019 | $2.92B | $13.2B |
| FY2020, ended Dec 31, 2020 | −$5.54B | $1.66B |
| FY2021, ended Dec 31, 2021 | $15.6B | $21.1B |
| FY2022, ended Dec 31, 2022 | $35.5B | $37.6B |
| FY2023, ended Dec 31, 2023 | $21.4B | $19.8B |
| FY2024, ended Dec 31, 2024 | $17.7B | $15.0B |
| FY2025, ended Dec 31, 2025 | $12.3B | $16.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $20.6B | $27.0B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.99B |
| FY2017, ended Dec 31, 2017 | $4.81B |
| FY2018, ended Dec 31, 2018 | $9.34B |
| FY2019, ended Dec 31, 2019 | $6.91B |
| FY2020, ended Dec 31, 2020 | $5.60B |
| FY2021, ended Dec 31, 2021 | $5.64B |
| FY2022, ended Dec 31, 2022 | $17.7B |
| FY2023, ended Dec 31, 2023 | $8.18B |
| FY2024, ended Dec 31, 2024 | $8.26B |
| FY2025, ended Dec 31, 2025 | $7.29B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.58B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $43.3B |
| FY2017, ended Dec 31, 2017 | $35.4B |
| FY2018, ended Dec 31, 2018 | $29.5B |
| FY2019, ended Dec 31, 2019 | $22.0B |
| FY2020, ended Dec 31, 2020 | $27.2B |
| FY2021, ended Dec 31, 2021 | $25.9B |
| FY2022, ended Dec 31, 2022 | $23.3B |
| FY2023, ended Dec 31, 2023 | $20.8B |
| FY2024, ended Dec 31, 2024 | $24.5B |
| FY2025, ended Dec 31, 2025 | $40.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $37.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 4.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.89B |
| FY2017, ended Dec 31, 2017 | 1.91B |
| FY2018, ended Dec 31, 2018 | 1.90B |
| FY2019, ended Dec 31, 2019 | 1.88B |
| FY2020, ended Dec 31, 2020 | 1.93B |
| FY2021, ended Dec 31, 2021 | 1.95B |
| FY2022, ended Dec 31, 2022 | 1.91B |
| FY2023, ended Dec 31, 2023 | 1.86B |
| FY2024, ended Dec 31, 2024 | 1.76B |
| FY2025, ended Dec 31, 2025 | 2.00B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.98B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Used in acquisitions |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.00M | — |
| FY2017, ended Dec 31, 2017 | $1.00M | — |
| FY2018, ended Dec 31, 2018 | $1.75B | — |
| FY2019, ended Dec 31, 2019 | $4.04B | — |
| FY2020, ended Dec 31, 2020 | $1.76B | $4.89B |
| FY2021, ended Dec 31, 2021 | $1.38B | $46.0M |
| FY2022, ended Dec 31, 2022 | $11.3B | — |
| FY2023, ended Dec 31, 2023 | $14.9B | $6.52B |
| FY2024, ended Dec 31, 2024 | $15.2B | — |
| FY2025, ended Dec 31, 2025 | $12.1B | $50.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $11.1B | — |
Valuation
At current price- Market Cap
- $451B
- P/E
- 21.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.1×
- Price / Book
- 2.4×
- EV / EBITDA
- 8.8×
Growth
Trailing 12 months- Revenue (TTM)
- $215B
- Revenue Growth YoY
- 10.2%
- Revenue CAGR 3Y
- −8.4%
- Revenue CAGR 5Y
- 14.8%
- EPS Growth YoY
- 33.7%
- Net Income Growth YoY
- 50.1%
Profitability
Trailing 12 months- Gross Margin
- 45.4%
- Operating Margin
- 14.2%
- Net Margin
- 9.6%
- FCF Margin
- 12.5%
- Return on Equity
- 12.2%
Earnings
Trailing 12 months- Net Income
- $20.6B
- EPS (diluted)
- $10.39
- EBITDA
- $54.2B
- Operating Income
- $30.6B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $9.58B
- Total Debt
- $37.1B
- Net Debt
- $27.5B
- Total Assets
- $330B
- Total Liabilities
- $135B
- Shareholders' Equity
- $190B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $45.3B
- Capital Expenditure
- $18.3B
- Free Cash Flow
- $27.0B
Dividends and risk
Last 12 months- Dividend Yield
- 3.1%
- Dividend / Share
- $7.05
- Beta (5Y)
- 0.54
Every ratio is calculated from the company’s reported figures.